|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
By Brian Marckx, CFA NASDAQ:CBMX Q3 2017: Results Remain Very Strong, Despite Record Revenue Streak Ending… CombiMatrix (NASDAQ:CBMX) reported financial results for Q3. While financial results remained ...
Momentum in base business complemented by strategic expansion into family health genetics Hosting conference call today at 4:30 pm ET / 1:30 pm PT SAN FRANCISCO , Nov. 6, 2017 /PRNewswire/ -- Invitae ...
NEW YORK , Oct. 12, 2017 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...
SAN FRANCISCO, Oct. 6, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced that it has commenced an offer to exchange (the "Exchange Offer") each outstanding Series F warrant (CUSIP No. 20009T147) (the "CombiMatrix Series F Warrants") to acquire one share of common stock of CombiMatrix Corporation ("CombiMatrix") for 0.3056 of a share of common stock, par value $0.0001 per share, of Invitae (the "Invitae Common Stock"). The Exchange Offer will expire at 12:00 midnight, New York City time, on November 13, 2017 (one minute after 11:59 p.m., New York City time, on November 12, 2017), or any other date and time to which Invitae extends the Exchange Offer (such date and time, as it may be extended, the "Expiration Date").
Categories: Yahoo FinanceGet free summary analysis CombiMatrix Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of CombiMatrix Corp. – Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics, Inc. and RadNet, Inc. (DGX-US, LH-US, NEO-US and RDNT-US) that have also reported for this period. Highlights ... Read more (Read more...)
NEW YORK, NY / ACCESSWIRE / August 2, 2017 / A strong earnings season continued to push U.S. markets higher Tuesday. The Dow Jones Industrial Average closed at a new record high for the 5th consecutive ...
Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with InVitae Corp (NYSE:NVTA)
SAN FRANCISCO, July 31, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced two acquisitions to establish a leading position in family health genetic information services. Invitae has entered into a definitive agreement to acquire privately held Good Start Genetics, a molecular diagnostics company focused on preimplantation and carrier screening for inherited disorders.
NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Positive economic data and continued strength in corporate earnings pushed U.S. markets into the green Friday. The Dow Jones Industrial Average gained 0.26 percent ...
NEW YORK, May 2, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of CombiMatrix Corporation (CBMX). You may also contact Robert H. Lefkowitz, Esq. Purcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct.
NEW YORK, NY / ACCESSWIRE / March 30, 2017 / CombiMatrix and Vertex Pharmaceuticals have made investors optimistic about the future of their companies as both stocks find broader markets for their products. ...